Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The present study is designed to collect safety/tolerability data and explore the efficacy of
RAD001 in advanced pulmonary neuroendocrine tumor in Chinese patients.